Cargando…
A double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: A pilot study
Uric acid has been linked with increased risk of chronic disease such as cardiovascular disease and this association has been attributed to a pro-inflammatory effect. Indeed, observational studies have shown that high uric acid is associated with high level of pro-inflammatory cytokines in the blood...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546625/ https://www.ncbi.nlm.nih.gov/pubmed/28786993 http://dx.doi.org/10.1371/journal.pone.0181100 |
_version_ | 1783255584651345920 |
---|---|
author | Tanaka, Toshiko Milaneschi, Yuri Zhang, Yongqing Becker, Kevin G. Zukley, Linda Ferrucci, Luigi |
author_facet | Tanaka, Toshiko Milaneschi, Yuri Zhang, Yongqing Becker, Kevin G. Zukley, Linda Ferrucci, Luigi |
author_sort | Tanaka, Toshiko |
collection | PubMed |
description | Uric acid has been linked with increased risk of chronic disease such as cardiovascular disease and this association has been attributed to a pro-inflammatory effect. Indeed, observational studies have shown that high uric acid is associated with high level of pro-inflammatory cytokines in the blood. However, whether high uric acid directly affects inflammation or rather represents a parallel defensive antioxidant mechanism in response to pathology that causes inflammation is unknown. To determine whether acute increase or decrease uric acid levels affects inflammation in healthy individuals, a randomized, placebo-controlled, double blind clinical study of uric acid or rasburicase with 20 healthy volunteers in each treatment-placebo group was conducted at the National Institute on Aging (NIA) Clinical Research Unit (CRU) at Harbor Hospital in Baltimore, MD. Change in inflammatory response was assessed by administering an oral lipid tolerance before and after the treatment of uric acid, rasburicase and placebo. Following uric acid administration, there was an accentuated increase in IL-6 during the oral lipid tolerance test (P<0.001). No significant differences were observed after lowering of uric acid with rasburicase. No side effects were reported throughout the trial. In health individuals, acute increase in uric acid results in an increased IL-6 response when challenged with lipid load. Such effect of amplification of inflammatory response may explain the higher risk of chronic diseases observed in subclinical hyperuricemia in observational studies. Trial Registration: ClinicalTrials.gov NCT01323335 |
format | Online Article Text |
id | pubmed-5546625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55466252017-08-12 A double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: A pilot study Tanaka, Toshiko Milaneschi, Yuri Zhang, Yongqing Becker, Kevin G. Zukley, Linda Ferrucci, Luigi PLoS One Research Article Uric acid has been linked with increased risk of chronic disease such as cardiovascular disease and this association has been attributed to a pro-inflammatory effect. Indeed, observational studies have shown that high uric acid is associated with high level of pro-inflammatory cytokines in the blood. However, whether high uric acid directly affects inflammation or rather represents a parallel defensive antioxidant mechanism in response to pathology that causes inflammation is unknown. To determine whether acute increase or decrease uric acid levels affects inflammation in healthy individuals, a randomized, placebo-controlled, double blind clinical study of uric acid or rasburicase with 20 healthy volunteers in each treatment-placebo group was conducted at the National Institute on Aging (NIA) Clinical Research Unit (CRU) at Harbor Hospital in Baltimore, MD. Change in inflammatory response was assessed by administering an oral lipid tolerance before and after the treatment of uric acid, rasburicase and placebo. Following uric acid administration, there was an accentuated increase in IL-6 during the oral lipid tolerance test (P<0.001). No significant differences were observed after lowering of uric acid with rasburicase. No side effects were reported throughout the trial. In health individuals, acute increase in uric acid results in an increased IL-6 response when challenged with lipid load. Such effect of amplification of inflammatory response may explain the higher risk of chronic diseases observed in subclinical hyperuricemia in observational studies. Trial Registration: ClinicalTrials.gov NCT01323335 Public Library of Science 2017-08-07 /pmc/articles/PMC5546625/ /pubmed/28786993 http://dx.doi.org/10.1371/journal.pone.0181100 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Tanaka, Toshiko Milaneschi, Yuri Zhang, Yongqing Becker, Kevin G. Zukley, Linda Ferrucci, Luigi A double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: A pilot study |
title | A double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: A pilot study |
title_full | A double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: A pilot study |
title_fullStr | A double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: A pilot study |
title_full_unstemmed | A double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: A pilot study |
title_short | A double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: A pilot study |
title_sort | double blind placebo controlled randomized trial of the effect of acute uric acid changes on inflammatory markers in humans: a pilot study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546625/ https://www.ncbi.nlm.nih.gov/pubmed/28786993 http://dx.doi.org/10.1371/journal.pone.0181100 |
work_keys_str_mv | AT tanakatoshiko adoubleblindplacebocontrolledrandomizedtrialoftheeffectofacuteuricacidchangesoninflammatorymarkersinhumansapilotstudy AT milaneschiyuri adoubleblindplacebocontrolledrandomizedtrialoftheeffectofacuteuricacidchangesoninflammatorymarkersinhumansapilotstudy AT zhangyongqing adoubleblindplacebocontrolledrandomizedtrialoftheeffectofacuteuricacidchangesoninflammatorymarkersinhumansapilotstudy AT beckerkeving adoubleblindplacebocontrolledrandomizedtrialoftheeffectofacuteuricacidchangesoninflammatorymarkersinhumansapilotstudy AT zukleylinda adoubleblindplacebocontrolledrandomizedtrialoftheeffectofacuteuricacidchangesoninflammatorymarkersinhumansapilotstudy AT ferrucciluigi adoubleblindplacebocontrolledrandomizedtrialoftheeffectofacuteuricacidchangesoninflammatorymarkersinhumansapilotstudy AT tanakatoshiko doubleblindplacebocontrolledrandomizedtrialoftheeffectofacuteuricacidchangesoninflammatorymarkersinhumansapilotstudy AT milaneschiyuri doubleblindplacebocontrolledrandomizedtrialoftheeffectofacuteuricacidchangesoninflammatorymarkersinhumansapilotstudy AT zhangyongqing doubleblindplacebocontrolledrandomizedtrialoftheeffectofacuteuricacidchangesoninflammatorymarkersinhumansapilotstudy AT beckerkeving doubleblindplacebocontrolledrandomizedtrialoftheeffectofacuteuricacidchangesoninflammatorymarkersinhumansapilotstudy AT zukleylinda doubleblindplacebocontrolledrandomizedtrialoftheeffectofacuteuricacidchangesoninflammatorymarkersinhumansapilotstudy AT ferrucciluigi doubleblindplacebocontrolledrandomizedtrialoftheeffectofacuteuricacidchangesoninflammatorymarkersinhumansapilotstudy |